“Billionaire Ken Griffin Increased His Position in This Dividend King by 547%”
September 29, 2026
“He’s known for buying stocks at lower valuations and watching those investments pay off. One of those plays this year was his purchase of an additional 2.68 million shares of healthcare giant AbbVie (NYSE: ABBV). The move increased his hedge fund’s exposure to the stock by 547%….
He’s owned stock in the company since 2013, and his most recent purchase is already paying off. AbbVie is trading at about $260 per share, while Citadel spent an average of $214.90 per share in its most recent AbbVie buy…”